<- Go Home
Lucy Scientific Discovery Inc.
Lucy Scientific Discovery Inc., an early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products. The company offers biological raw materials, active pharmaceutical ingredients (APIs), and finished biopharmaceutical products. It also develops and produces highly controlled agricultural grow environments for plant manufacturing and replication applications. The company was formerly known as Hollyweed North Cannabis Inc. and changed its name to Lucy Scientific Discovery Inc. in May 2021. Lucy Scientific Discovery Inc. was incorporated in 2017 and is headquartered in Victoria, Canada.
Market Cap
$882.00
Volume
62.0K
Cash and Equivalents
$211.1K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$8.4K
Profit Margin
49.99%
52 Week High
$4.10
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
0.01
Price / Earnings
-0.00
Price / Tangible Book Value
-0.00
Enterprise Value
-$140.7K
Enterprise Value / EBITDA
N/A
Operating Income
-$7.2M
Return on Equity
305.26%
Return on Assets
-99.35
Cash and Short Term Investments
$211.1K
Debt
$69.5K
Equity
$81.2K
Revenue
$16.7K
Unlevered FCF
-$5.6M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium